JiangXi Tianxin Pharmaceutical Co., Ltd. (SHA:603235)
China flag China · Delayed Price · Currency is CNY
26.38
0.00 (0.00%)
At close: Apr 28, 2026

SHA:603235 Revenue

In the year 2025, JiangXi Tianxin Pharmaceutical had annual revenue of 2.35B CNY with 6.18% growth. JiangXi Tianxin Pharmaceutical had revenue of 714.10M in the quarter ending December 31, 2025, with 20.02% growth.

Revenue
2.35B
Revenue Growth
+6.18%
P/S Ratio
4.90
Revenue / Employee
875.34K
Employees
2,679
Market Cap
11.48B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20252.35B136.47M6.18%
Dec 31, 20242.21B326.58M17.35%
Dec 31, 20231.88B-422.80M-18.34%
Dec 31, 20222.30B-217.64M-8.63%
Dec 31, 20212.52B218.84M9.50%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition